Kim K - Search Results

1

Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.

Kim K, Duarte JD, Galanter WL, Han J, Lee JC, Cavallari LH, Nutescu EA. Kim K, et al. Pharmacogenomics. 2023 Apr;24(6):303-314. doi: 10.2217/pgs-2023-0014. Epub 2023 May 11. Pharmacogenomics. 2023. PMID: 37166395

2

Cost-Effectiveness of Strategies to Personalize the Selection of P2Y₁₂ Inhibitors in Patients with Acute Coronary Syndrome.

Kim K, Touchette DR, Cavallari LH, Ardati AK, DiDomenico RJ. Kim K, et al. Cardiovasc Drugs Ther. 2019 Oct;33(5):533-546. doi: 10.1007/s10557-019-06896-8. Cardiovasc Drugs Ther. 2019. PMID: 31367811

3

Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing.

Zolekar A, Kim K, Lee JC, Han J, Duarte JD, Galanter WL, Cavallari LH, Nutescu EA. Zolekar A, et al. Among authors: kim k. Pharmacogenomics. 2022 Jan;23(2):85-95. doi: 10.2217/pgs-2021-0109. Epub 2022 Jan 10. Pharmacogenomics. 2022. PMID: 35001645 Free article.

4

Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women.

Parab AZ, Kong A, Lee TA, Kim K, Nutescu EA, Malecki KC, Hoskins KF, Calip GS. Parab AZ, et al. Among authors: kim k. JAMA Netw Open. 2024 Apr 1;7(4):e244862. doi: 10.1001/jamanetworkopen.2024.4862. JAMA Netw Open. 2024. PMID: 38568689 Free PMC article.

5

Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes.

Kim K, Biskupiak JE, Babin JL, Ilham S. Kim K, et al. Healthcare (Basel). 2022 Dec 30;11(1):115. doi: 10.3390/healthcare11010115. Healthcare (Basel). 2022. PMID: 36611576 Free PMC article.

6

Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome.

Kim K, Lee TA, Touchette DR, DiDomenico RJ, Ardati AK, Walton SM. Kim K, et al. J Manag Care Spec Pharm. 2018 Aug;24(8):800-812. doi: 10.18553/jmcp.2018.24.8.800. J Manag Care Spec Pharm. 2018. PMID: 30058986 Free PMC article.

7

Pregabalin Does Not Increase Risk of Heart Failure Exacerbation in Patients With Pre-existing Heart Failure.

Wynn E, Biskupiak J, Kim K, Munger MA. Wynn E, et al. Among authors: kim k. Ann Pharmacother. 2024 Jan;58(1):15-20. doi: 10.1177/10600280231165259. Epub 2023 Apr 12. Ann Pharmacother. 2024. PMID: 37042315

8

Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome.

Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette DR, Walton SM. Kim K, et al. Pharmacotherapy. 2017 Aug;37(8):877-887. doi: 10.1002/phar.1961. Epub 2017 Jul 18. Pharmacotherapy. 2017. PMID: 28555946

9

Cancer incidence in immunocompromised patients: a single-center cohort study.

Ilham S, Willis C, Kim K, Chung KC, Wood BM, Tan MS, Tan CJ, Nguyen DT, Brixner DI, Stenehjem DD. Ilham S, et al. Among authors: kim k. BMC Cancer. 2023 Jan 9;23(1):33. doi: 10.1186/s12885-022-10497-4. BMC Cancer. 2023. PMID: 36624408 Free PMC article.

10

Cost-Effectiveness of a Pharmacist-Led Medication Therapy Management Clinic for Management of Type 2 Diabetes.

Joshi M, Pham C, Deng H, Mathew S, Norton RM, Kim K, Touchette DR, Tilton JJ. Joshi M, et al. Among authors: kim k. J Am Pharm Assoc (2003). 2024 Sep 23:102253. doi: 10.1016/j.japh.2024.102253. Online ahead of print. J Am Pharm Assoc (2003). 2024. PMID: 39322027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,833 results

Search Page

Filters